GSK3B and cancer: Given that the down-regulation of GSK3β/β-catenin activity appears to decrease the tumorigenic potential of hepato-carcinoma cells, molecules that are involved in the AMPK-mediated regulation of GSK3β, such as anthocyanins, could serve as potential therapeutic targets for the suppression of cancer progression and metastasis.